USHY 📈 iShares Broad USD High - Overview
Exchange: BATS • Country: USA • Currency: USD • Type: Etf • ISIN: US46435U8532 • High Yield Bond
USHY: High Yield Bonds, Corporate Debt, Fixed Income Securities
The iShares Broad USD High Yield Corporate Bond ETF, traded on BATS under the ticker USHY, is designed to offer investors exposure to the U.S. dollar-denominated high yield corporate bond market. By investing at least 80% of its assets in the component securities of its underlying index, the fund aims to closely track the performance of this market segment. Furthermore, it allocates at least 90% of its assets in fixed income securities that are representative of the types included in the underlying index, as determined by BFA, the fund's manager. This strategy is intended to provide a broad and diversified portfolio that mirrors the underlying index's composition.
The underlying index of the USHY ETF is specifically crafted to provide a comprehensive representation of the U.S. high yield corporate bond market. This includes a wide range of corporate bonds issued by companies in various sectors, with the common trait of being U.S. dollar-denominated and classified as high yield. The high yield designation typically signifies that these bonds carry a higher credit risk compared to investment-grade bonds, which can result in higher potential returns to compensate for this increased risk. By tracking this index, the USHY ETF offers investors a tool to gain exposure to this segment of the fixed income market, potentially enhancing the yield of their investment portfolios.
In terms of its structure, the USHY ETF is classified as an exchange-traded fund (ETF), belonging to the high yield bond category. It is domiciled in the United States and has the ISIN code US46435U8532. As an ETF, it combines the trading flexibility of stocks with the diversified investment benefits of mutual funds, allowing investors to buy and sell shares throughout the trading day. This liquidity, coupled with its broad coverage of the U.S. high yield corporate bond market, makes the USHY ETF an attractive option for investors seeking to diversify their fixed income holdings or to increase their portfolio's yield potential.
Additional Sources for USHY ETF
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
USHY ETF Overview
Market Cap in USD | 20,612m |
Category | High Yield Bond |
TER | 0.08% |
IPO / Inception | 2017-10-25 |
USHY ETF Ratings
Growth 5y | 47.3% |
Fundamental | - |
Dividend | 60.6% |
Rel. Strength Industry | 209 |
Analysts | - |
Fair Price Momentum | 36.75 USD |
Fair Price DCF | - |
USHY Dividends
Dividend Yield 12m | 6.29% |
Yield on Cost 5y | 7.61% |
Annual Growth 5y | -1.22% |
Payout Consistency | 82.0% |
USHY Growth Ratios
Growth Correlation 3m | 50.3% |
Growth Correlation 12m | 96.9% |
Growth Correlation 5y | 58.2% |
CAGR 5y | 3.90% |
CAGR/Mean DD 5y | 0.95 |
Sharpe Ratio 12m | 0.71 |
Alpha | -8.18 |
Beta | 0.49 |
Volatility | 5.98% |
Current Volume | 6095.7k |
Average Volume 20d | 13421.3k |
As of December 27, 2024, the stock is trading at USD 36.75 with a total of 6,095,733 shares traded.
Over the past week, the price has changed by +0.46%, over one month by -0.50%, over three months by +0.09% and over the past year by +8.02%.
Partly, yes. Based on ValueRay Analyses, iShares Broad USD High (BATS:USHY) is currently (December 2024) ok to buy, but has to be watched. It has a Growth Technical Rating of 47.32 and therefor an somewhat technical positive rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of USHY as of December 2024 is 36.75. This means that USHY is currently overvalued and has a potential downside of 0%.
iShares Broad USD High has no consensus analysts rating.
According to ValueRays Forecast Model, USHY iShares Broad USD High will be worth about 40.2 in December 2025. The stock is currently trading at 36.75. This means that the stock has a potential upside of +9.39%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 40.2 | 9.4% |